openPR Logo
Press release

Global Nerve Stimulator Devices Market Expected to Grow at a CAGR of 12.6% by 2027 | Nevro Corporation, Synapse biomedical, Bio Control Medical, Cyberonics Incorporation, Boston Scientific Corporation, Abbott, Medtronic, Neuro Sigma, St. Jude Medical

08-02-2019 12:04 PM CET | Health & Medicine

Press release from: Research Nester Pvt Ltd

Research Nester

Research Nester

According to a recently published report by Research Nester on “Global Nerve Stimulator Device Market Outlook: Industry Insights & Opportunity Assessment 2019–2027” delivers detailed overview of the global nerve stimulator device market in terms of market segmentation by product, by application, by end user and by region.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.

Neurostimulation devices or nerve stimulator devices aid to provide control using the electrical stimulation of specific nerves in the body. These devices are highly beneficial in reducing pain related to neurological disorders such as chronic pain, epilepsy, major depression, Parkinson’s disease, and others. They also help to reduce the pain of paralyzed patients. These devices are operationally set in the patient’s body and functions are performed by thin wires or leads. New technologies are being developed and researchers are revealing more potential uses of this treatment which is fueling the demand for safe and cost effective treatment options. The need to develop enhanced models of neuro-simulation devices is estimated to boost the growth of the global nerve stimulator device market with a CAGR of 12.6% over the period 2019-2027.

The global nerve stimulator device market is segmented by product, application and end user. By end user, the hospitals segment is estimated to dominate the market during the forecast period. The product segment is divided into deep brain simulation devices, spinal cord simulation devices, gastric electric simulation devices, vagus nerve simulation devices, sacral nerve simulation devices and others. The application segment has been divided into Parkinson’s disease, epilepsy, pain management, essential tremor, urinary and fecal incontinence, Alzheimer’s, ischemia and others. Further the end user segment, is divided into hospitals, scientific research laboratories and others.

Request Free Sample on Nerve Stimulator Devices Market @ https://www.researchnester.com/sample-request-1656

Increasing Prevalence of Chronic Diseases to Boost the Demand for Nerve Stimulator Devices in Future

The global nerve stimulator device market is thriving on the back of increase in prevalence of chronic diseases such as migraine, epilepsy and others due to unhealthy diet and changing lifestyle of the people.

Rising geriatric population- With the rise in the geriatric population across the globe, the threat of being prone to various disease has inclined which includes different diseases such as Parkinson’s, Alzheimer’s and others that requires neurological treatment which can be done with the help of nerve stimulator devices.

North America and Europe are expected to hold major share in the market owing to the growing awareness regarding preventive care, increasing neurological diseases such as epilepsy, migraine, Parkinson’s disease, and incontinence, emerging technologies in the neurostimulation devices market and the gradual shift of preferences of the patients towards utilization of advanced medical devices. Asia Pacific is expected to grow at a high pace on the back of high economic growth, presence of a vast patient pool, improving facilities in healthcare largely owing to the expansion of both public and private sector companies that have been collaborating with multinational healthcare establishments to provide better treatment options. Latin America and the Middle East and Africa are expected to grow significantly owing to the rapidly growing healthcare infrastructure and opportunities and funds provided by the government to the manufacturers to conduct research activities for improved patient care.

The nerve stimulator devices perform specific functions which means that they are supposed to be specifically designed and programmed which make them costlier. The cost of nerve stimulator devices is high which pushes the customers towards other available options of treatment for neurological disorders which is expected to inhibit the growth of the global nerve stimulator device market.

This report also provides the existing competitive scenario of some of the key players of the global nerve stimulator market which includes company profiling of Nevro Corporation, Synapse biomedical, Bio Control Medical, Cyberonics Incorporation, Boston Scientific Corporation, Abbott, Medtronic, Neuro Sigma, St. Jude Medical and NeuroPace Incorporation.

The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global nerve stimulator device market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
For More Details: https://www.researchnester.com/reports/global-nerve-stimulator-market/1656

Contact Us

AJ Daniel
Email: sales@researchnester.com
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919

About Research Nester

Research Nester is a one-stop service provider with a client base in more than 50 countries, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives for their future investment while avoiding forthcoming uncertainties. With an out-of-the-box mindset to produce statistical and analytical market research reports, we provide strategic consulting so that our clients can make wise business decisions with clarity while strategizing and planning for their forthcoming needs and succeed in achieving their future endeavors. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Nerve Stimulator Devices Market Expected to Grow at a CAGR of 12.6% by 2027 | Nevro Corporation, Synapse biomedical, Bio Control Medical, Cyberonics Incorporation, Boston Scientific Corporation, Abbott, Medtronic, Neuro Sigma, St. Jude Medical here

News-ID: 1817298 • Views:

More Releases from Research Nester Pvt Ltd

Chemical Fertilizers Market Outlook By Industry Size, Share, Revenue, Regions And Top Key Players Analysis From 2017-2024
Chemical Fertilizers Market Outlook By Industry Size, Share, Revenue, Regions An …
The chemical fertilizers market has been segmented into macronutrients, micronutrients, application and forms. Based on macronutrients, the market has been segmented into nitrogen based fertilizers, phosphate based fertilizers and potash based fertilizers. Among these segments, the nitrogen based fertilizers are estimated to dominate the market by holding the largest share of approximately 50%. This can be attributed to the absorption of nitrogen by plants. In 2013, the demand for nitrogen
Glass Coating Market Overview By Share, Size, Industry Players, Revenue And Product Demand Forecast Till 2027
Glass Coating Market Overview By Share, Size, Industry Players, Revenue And Prod …
The global glass coating market is segmented by coating type into pyrolytic coating, magnetic sputtering coating and sol-gel coating; by technology into liquid glass coating and nano glass coating; by application into construction, paints & coating, automotive, aviation and others and by regions. According to Federal Reserve Bank of Chicago represents increase in sales of light vehicle in China by 2.1%, Latin America by 6.2%, Europe by 2.6%, and Rest
Insect Repellent Market Outlook By Industry Size, Share, Revenue, Regions And Top Key Players Analysis From 2019-2027
Insect Repellent Market Outlook By Industry Size, Share, Revenue, Regions And To …
The global insect repellent market is segmented by repellent type into coils, liquid vaporizers, sprays/aerosol, mats, cream and oil; by ingredient into natural and synthetic; by sales channel into online and offline and by regions. The insect repellent market is anticipated to mask a CAGR of 8.3% during the forecast period i.e. 2019-2027. The rising penetration of insect repellents in untapped rural markets across the developing countries as well as
Waterproofing Chemicals Market 2017 Share Growing Rapidly With Latest Trends, Development, Revenue, Demand And Forecast To 2027
Waterproofing Chemicals Market 2017 Share Growing Rapidly With Latest Trends, De …
The global waterproofing market is segmented on the basis of type, application and end-use. The market is segmented on the basis of type, it is segmented into Bitumen, PVC, TPO and EPDM. Bitumen leads the product segment in 2017 on the account of superior properties which include high viscosity, resistance to UV light and better binding nature. On the basis of application, it is segmented into Roofing and Walls, Flooring,

All 4 Releases


More Releases for Parkinson’s

Parkinson’s Disease Therapeutics Market 2021 | Detailed Report
Global Parkinson’s Disease Therapeutics Market 2021-2027, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample PDF (including full TOC, Tables and
Parkinson’s Disease Treatment Market 2021 | Detailed Report
Parkinson’s Disease Treatment Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027. Get Free Sample PDF (including full TOC, Tables and Figures) of Parkinsons Disease Treatment Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5024082 The report provides a comprehensive analysis of company profiles listed below: - Teva - Roche - Prothena - Acorda
Parkinson’s disease Therapeutics Parkinson’s disease Therapeutics Market to …
This report studies the global Parkinson's Disease Therapeutics market, analyzes and researches the Parkinson's Disease Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like GSK Novartis Boehringer Ingelheim Teva Pharmaceutical Abbvie ….. Ask for sample copy @ https://www.researchtrades.com/request-sample/1199125 Market segment by Regions/Countries, this report covers United States EU Japan China India Southeast Asia Market segment by Type, Parkinson's Disease Therapeutics can be split into Medications Therapeutics Medical Devices Therapeutics Buy
US Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in the United States in recent years and it most likely to continue rising in the near future. It has been estimated that at least 500,000 people in the United States currently have been diagnosed with this disease. The society pays a significant amount towards treating this disease in the country. It is estimated that the total cost to the nation exceeds
Europe Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in Europe in recent years and it most likely to continue rising in the near future. It has been estimated that currently, more than 1 million in Europe are affected by Parkinson’s disease. This figure is most likely to double by 2030. Among the most common neurodegenerative disease (after Alzheimer’s disease), Parkinson’s is the second most common and it is expected that
Parkinson’s Disease - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Parkinson’s Disease - Heat Map and Analysis to its growing collection of premium market research reports. Parkinson’s disease (PD) is a chronic and progressive neurodegenerative disorder characterized by the progressive loss of muscular control, leading to resting tremor, rigidity, akinesia and postural reflex impairment. PD is an age-related disorder; symptoms typically begin to first appear in patients in their mid-sixties,